Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Adavanced or Metastatic Renal Cells Cancer

Conditions: Renal Cell Carcinoma Metastatic; Renal Cell Carcinoma Stage IV; Renal Cell Carcinoma Stage III Interventions: Drug: Cabozantinib Sponsors: Fundacion Oncosur Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials